The pattern of expression of protease-activated receptors (PARs) during early trophoblast development.
Human fetal development depends on the ability of the embryo to gain access to the maternal circulation. Thus, specialized stem cells of the newly formed placenta, trophoblast, invade the uterus and its arterial network to establish an efficient feto-maternal molecular exchange. To accomplish this task, trophoblast differentiation during the first trimester of pregnancy involves cell proliferation, invasion, and extracellular matrix (ECM) remodelling. Trophoblast invasion shares many features with tumour cell invasion, with the distinction that it is strictly spatially and temporally controlled. We have previously demonstrated that PAR1, the first member of the protease-activated receptor (PAR) family, plays a central role in tumour cell invasion. In the present study we have examined the pattern of expression of PAR1 and other PAR family candidates during early human placental development. We show that PAR1 and PAR3 are highly and spatially expressed between the 7th and 10th weeks of gestation but not at the 12th week and thereafter. Likewise, high expression levels of PAR1 and PAR3 were observed in the cytotrophoblast cells of complete hydatidiform mole as compared to minimal levels in normal age-matched placenta. Together, our data suggest the involvement of PAR1 and PAR3 in restricted and unrestricted pathological trophoblast invasion.
Even-Ram
Sharona Cohen
SC
Department of Oncology, Pathology, Hadassah University Hospital, Jerusalem, Israel.
Grisaru-Granovsky
Sorina
S
Pruss
Diana
D
Maoz
Miriam
M
Salah
Zaidoun
Z
Yong-Jun
Yin
Y
Bar-Shavit
Rachel
R
D002824:Chorionic Villi / Q000378:metabolism; D015536:Down-Regulation / Q000502:physiology; D005109:Extracellular Matrix / Q000378:metabolism; D005260:Female; D006801:Humans; D006828:Hydatidiform Mole / Q000378:metabolism; D007150:Immunohistochemistry / Q000379:methods; D017403:In Situ Hybridization / Q000379:methods; D008431:Maternal-Fetal Exchange / Q000502:physiology; D010920:Placenta / Q000378:metabolism*; D016133:Polymerase Chain Reaction / Q000379:methods; D011247:Pregnancy; D011257:Pregnancy Proteins / Q000032:analysis; D011261:Pregnancy Trimester, First / Q000502:physiology; D044463:Receptor, PAR-1; D018179:Receptors, Thrombin / Q000032:analysis*; D014327:Trophoblasts / Q000166:cytology / Q000502:physiology*
D011257:Pregnancy Proteins; D044463:Receptor, PAR-1; D018179:Receptors, Thrombin; C105295:protease-activated receptor 3